These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3063237)

  • 1. [The importance of apolipoproteins in dyslipidemias].
    Quintão EC
    Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237
    [No Abstract]   [Full Text] [Related]  

  • 2. New aspects in lipidology and atherosclerosis.
    Superko HR
    Can J Cardiol; 1995 May; 11 Suppl C():4C-8C. PubMed ID: 7750049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future genetic-epidemiological research in coronary heart disease: the decade of the apolipoproteins, dysapolipoproteinemia, and dyslipoproteinemia.
    Glueck CJ
    Prog Clin Biol Res; 1984; 147():525-32. PubMed ID: 6377319
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoproteins, dyslipoproteinaemia and premature coronary heart disease.
    Hamsten A
    Acta Med Scand; 1988; 223(5):389-403. PubMed ID: 3287836
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma lipoproteins and coronary arteriosclerosis].
    Sznajderman M
    Przegl Lek; 1987; 44(6):508-9. PubMed ID: 3685436
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoproteins and apolipoproteins in the prediction of coronary artery disease.
    Assmann G
    Acta Med Scand Suppl; 1987; 715():67-77. PubMed ID: 3473917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis].
    Morimoto S; Hiasa Y; Maeda T; Harada M; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1986 Nov; 34(11):1221-6. PubMed ID: 3809751
    [No Abstract]   [Full Text] [Related]  

  • 11. New lipoprotein profiles and coronary heart disease. Improving precision of risk.
    Nestel PJ
    Circulation; 1990 Aug; 82(2):649-51. PubMed ID: 2372911
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of apolipoprotein polymorphism in a Hungarian population].
    Császár A
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2296-7. PubMed ID: 9340574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic studies in familial hyperlipoproteinemia, and therapeutic implications].
    de Gennes JL
    Ann Biol Clin (Paris); 1988; 46(1):1-3. PubMed ID: 3389574
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipoprotein (a): variability and association with coronary disease].
    Souza DR; Garcia MV
    Arq Bras Cardiol; 1994 Mar; 62(3):187-94. PubMed ID: 7980082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dyslipidemias and coronary disease].
    Douste-Blazy P; Douste-Blazy L
    Ann Biol Clin (Paris); 1986; 44(5):559-64. PubMed ID: 3544979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse.
    Fazio S; Linton MF
    Circulation; 2005 Jun; 111(25):3349-51. PubMed ID: 15983260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-insulin-dependent diabetes mellitus and atherosclerosis: a lipoprotein perspective.
    Hamsten A; Steiner G
    J Intern Med Suppl; 1994; 736():1-3. PubMed ID: 7986301
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum remnant lipoprotein levels in nephrotic syndrome.
    Kinoshita H; Uezono S; Fukudome K; Yokota N; Hisanaga S; Fujimoto S; Eto T
    Clin Nephrol; 2001 Mar; 55(3):263-4. PubMed ID: 11316252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?].
    Cybulska B
    Kardiol Pol; 2005 Feb; 62(2):153-6. PubMed ID: 15815801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.